|
|
|||
| |||||||||||||||||||||||||||||||||
Depurative therapy is life-sustaining for more than 300,000 patients with end-stage renal disease in the United States and for many others in whom acute renal failure develops during their hospital course. Yet the annual overall mortality in end-stage renal disease is over 20 percent, and in acute renal failure, survival is less than 50 percent numbers that have remained unchanged for many years. These dismal statistics attest to the imperfection of artificial renal-replacement therapy.
Complications of Dialysis catalogues the causes of the problems inherent in the treatment of renal failure. The editors have divided the complications into those related
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |